PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma.
Nat. Cancer
2023
4
10
1508-1525
Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion.
J Clin Invest
2023
133
21
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling.
J Hepatol
2023
79
2
296-313
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses.
Immunity
2023
56
6
1341-1358.e11
Transmicron: accurate prediction of insertion probabilities improves detection of cancer driver genes from transposon mutagenesis screens.
Nucleic Acids Res
2023
51
4
Ovulation is triggered by a cyclical modulation of gonadotropes into a hyperexcitable state.
Cell Rep
2023
42
6
Non-canonical functions of SNAIL drive context-specific cancer progression.
Nat Commun
2023
14
1
In vivo interrogation of regulatory genomes reveals extensive quasi-insufficiency in cancer evolution.
Cell Genom
2023
3
3
Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy.
Nat. Cancer
2023
4
4
454-467
An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets.
Cancer Cell
2023
41
7
1327-1344.e10